You searched for "innovation"
IACLE honors the recipients of the 2023 awards
Contact lens educators from three countries – Colombia, India, and Jordan – receive prestigious awards from the International Association of Contact Lens Educators (IACLE) for their outstanding contributions to contact lens education.The College of Optometrists awards its first Optometric Practice Educator (OptPE) affix to qualifying supervisors at the College’s AGM 2025
The College of Optometrists has awarded the first Optometric Practice Educator (OptPE) affix, it’s first-ever educational affix, to the inaugural group of optometrists who have completed the College’s enhanced training for supervisors. The OptPE affix is designed to recognise the...The Syrian Ophthalmologists Initiative (SOI): A lifeline to the future of ophthalmology in Syria
Syria, a nation with over 22 million people, has faced more than a decade of conflict that has severely impacted its healthcare infrastructure. Medical training has become fragmented, with many doctors lacking access to structured postgraduate education and essential clinical...Introducing the Interest in Ophthalmology Association
We are very excited to announce the launch of Interest in Ophthalmology Association (InOA), a brand-new organisation to unite and support all those interested in eye health and vision sciences, starting in 2026! What is InOA? The InOA is a...Corneal dystrophies simplified
Based on biomicroscopic and histopathologic features, corneal dystrophies can be broadly classified into epithelial, Bowman’s layer / anterior stromal, stromal, and endothelial dystrophies. Corneal dystrophies are a group of inherited, bilateral, gradually progressing, non- inflammatory conditions caused by accumulation of...
Intravitreal Ziv-Aflibercept: safety analysis
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Bleomycin for conjunctival lymphangioma
This is a retrospective review of 16 eyes which underwent intralesional / sub-conjunctival injections of bleomycin sclerotherapy for conjunctival lymphatic malformations (lymphangiomas). The mean age was 18 (range three to 59 years). Four of the lesions were microcystic and 12...
